Bioorthogonal Equipping CAR-T Cells with Hyaluronidase and Checkpoint Blocking Antibody for Enhanced Solid Tumor Immunotherapy | ACS Central Science
Blocking antibodies for SARS-CoV-2, ACE-2 and more: R&D Systems
A Neutralizing Antibody-Conjugated Photothermal Nanoparticle Captures and Inactivates SARS-CoV-2 | bioRxiv
Frontiers | Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection - ScienceDirect
COVID-19 Neutralizing Antibody Test | anptech
Vaccines | Free Full-Text | Overview of Neutralizing Antibodies and Their Potential in COVID-19
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: Trends in Immunology
Recombinant Mouse IgG Antibody
Turning antibodies off and on again using a covalently tethered blocking peptide | Communications Biology
Non-neutralizing antibodies and vaccine-induced protection against HIV | Future HIV Therapy
Reversible blocking of antibodies using bivalent peptide–DNA conjugates allows protease-activatable targeting - Chemical Science (RSC Publishing)
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
Peptide Blocking: Novus Biologicals
Passive antibody therapy in COVID-19 | Nature Reviews Immunology
Frontiers | Public Immunity: Evolutionary Spandrels for Pathway-Amplifying Protective Antibodies
LIBRA-seq: Accelerating antibody discovery
Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants | NEJM
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
Measuring Neutralizing Ability to SARS-CoV-2 Variant Spike Proteins | Bio-Techne
What is antibody therapy?
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells - ScienceDirect
Anta", "Block", "Neutra"...but Who Are They? - Innovative antibodies against haptens and transmembrane proteins
SARS-CoV-2 Neutralizing Antibodies | Sino Biological
R&D Systems Blocking/Neutralizing Antibodies: R&D Systems